Skip to search formSkip to main contentSkip to account menu

jorumycin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Tetrahydroisoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract 5587: Phase I study of PM00104 in combination with carboplatin in patients (pts) with advanced solid tumors
Background: PM00104 (Zalypsis ® ) is a synthetic alkaloid related to Jorumycin with a strong antitumor activity against a wide… 
2011
2011
Phase I study of PM00104 in combination with carboplatin (C) in patients (pts) with advanced solid tumors.
e13085 Background: PM00104 (Zalypsis, Z) is a synthetic alkaloid related to Jorumycin with a strong antitumor activity against a… 
2011
2011
Cell cycle and apoptotic effects of PM00104 in pediatric cell lines and xenographs.
9546 Background: PM00104 (Zalypsis) is a new synthetic alkaloid related to jorumycin and the renieramycins with in vitro growth… 
2009
2009
Phase I study of the novel anticancer drug PM00104 as a 24-hour IV infusion every 3 weeks (q3w) in patients (pts) with advanced solid tumors or lymphoma.
2568 Background: PM00104 is a novel synthetic alkaloid related to the marine compounds jorumycin and renieramycins. Preliminary… 
2006
2006
Formulations comprising compounds related to Jorumycin, renieramycin, safracin and saframycin and a disaccharide for treating proliferative diseases
A pharmaceutical composition comprising a disaccharide and a compound of general formula (I): wherein R1 is selected from the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)